LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 41

Search options

  1. Article ; Online: Decolonization and decontamination: what's their role in infection control?

    Vergnano, Stefania

    Current opinion in infectious diseases

    2015  Volume 28, Issue 3, Page(s) 207–214

    Abstract: Purpose of review: Hospital-acquired infections cause up to 19% of infections in paediatric patients contributing to the spread of antimicrobial resistance. This review evaluates the effect of decolonization and decontamination in hospitalized children ... ...

    Abstract Purpose of review: Hospital-acquired infections cause up to 19% of infections in paediatric patients contributing to the spread of antimicrobial resistance. This review evaluates the effect of decolonization and decontamination in hospitalized children and neonates as an adjunct to standard infection control measures.
    Recent findings: Few studies on decolonization and decontamination are available in children. The evidence about the effectiveness of daily chlorhexidine washcloths on bacteraemia in paediatric patients relies on a single randomized controlled trial, in neonates with central venous access in a single retrospective observational study. It is uncertain whether nasal mupirocin reduces methicillin-resistant Staphylococcus aureus carriage and infections in neonates, whereas oral chlorhexidine mouthwashes have not proven effective in children in intensive care settings. Scanty evidence demonstrates a reduction in the rate of ventilation-acquired pneumonia with digestive tract decontamination in paediatric patients and no studies are available in neonates. These strategies have not been extensively tested in resource-poor countries.
    Summary: Strong evidence about the efficacy of decolonization and decontamination interventions exists in adult medicine but not in paediatric patients. There is an urgent need to understand how these interventions could be adapted to neonates and resource-poor settings in which the prevalence of hospital-acquired infections is higher.
    MeSH term(s) Administration, Intranasal ; Anti-Bacterial Agents/therapeutic use ; Anti-Infective Agents, Local/therapeutic use ; Chlorhexidine/therapeutic use ; Cross Infection/prevention & control ; Decontamination/methods ; Digestive System/microbiology ; Female ; Humans ; Infection Control/methods ; Male ; Methicillin-Resistant Staphylococcus aureus/drug effects ; Methicillin-Resistant Staphylococcus aureus/growth & development ; Mupirocin/therapeutic use ; Nasal Cavity/microbiology ; Staphylococcal Infections/prevention & control
    Chemical Substances Anti-Bacterial Agents ; Anti-Infective Agents, Local ; Mupirocin (D0GX863OA5) ; Chlorhexidine (R4KO0DY52L)
    Language English
    Publishing date 2015-06
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 645085-4
    ISSN 1473-6527 ; 1535-3877 ; 0951-7375 ; 1355-834X
    ISSN (online) 1473-6527 ; 1535-3877
    ISSN 0951-7375 ; 1355-834X
    DOI 10.1097/QCO.0000000000000164
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: The impact of paediatric antimicrobial stewardship programmes on patient outcomes.

    Patel, Sanjay V / Vergnano, Stefania

    Current opinion in infectious diseases

    2018  Volume 31, Issue 3, Page(s) 216–223

    Abstract: Purpose of review: Although there has been an unprecedented global effort to reduce the spread of antimicrobial resistance, little emphasis has been placed on children. This review aims to evaluate the impact of paediatric antimicrobial stewardship ... ...

    Abstract Purpose of review: Although there has been an unprecedented global effort to reduce the spread of antimicrobial resistance, little emphasis has been placed on children. This review aims to evaluate the impact of paediatric antimicrobial stewardship programmes as well as providing a practical approach for effectively implementing them in community-based settings and in hospitals.
    Recent findings: Although rates of serious bacterial infection are low in children, the rates of antimicrobial use and resistance are comparable with adults. Different strategies are required to implement antimicrobial stewardship in community-based settings compared to in hospitals. Nationally coordinated, whole-system approaches have achieved long-term, sustainable reductions in antimicrobial prescribing, as well as reductions in resistance rates at population level, with no evidence of an increase in rate of serious infection or bacterial complications.
    Summary: Antimicrobial stewardship programmes in neonates and children have unique characteristics and issues. There is currently no consensus on how to measure consumption of antimicrobials in neonates and children. This is a research priority. Benchmarking and clinical networks in neonates and paediatrics are important to share practice and drive best use of antimicrobials.
    MeSH term(s) Adolescent ; Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship/statistics & numerical data ; Bacteria/drug effects ; Bacterial Infections/diagnosis ; Bacterial Infections/drug therapy ; Child ; Child, Preschool ; Drug Resistance, Bacterial ; Drug Utilization/standards ; Humans ; Infant ; Infant, Newborn ; Procedures and Techniques Utilization ; Treatment Outcome
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2018-04-17
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 645085-4
    ISSN 1473-6527 ; 1535-3877 ; 0951-7375 ; 1355-834X
    ISSN (online) 1473-6527 ; 1535-3877
    ISSN 0951-7375 ; 1355-834X
    DOI 10.1097/QCO.0000000000000449
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Narrowing the spectrum: development of a UK paediatric antimicrobial prescribing summary.

    Shears, Annalie / Demirjian, Alicia / McGarrity, Orlagh / Vergnano, Stefania / Patel, Sanjay Valabh / McMaster, Paddy

    Archives of disease in childhood

    2022  Volume 107, Issue 7, Page(s) 698–699

    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Child ; Drug Prescriptions ; Humans ; Inappropriate Prescribing ; United Kingdom
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2022-02-21
    Publishing country England
    Document type Letter
    ZDB-ID 524-1
    ISSN 1468-2044 ; 0003-9888 ; 1359-2998
    ISSN (online) 1468-2044
    ISSN 0003-9888 ; 1359-2998
    DOI 10.1136/archdischild-2022-323858
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: A Survey on National Pediatric Antibiotic Stewardship Programs, Networks and Guidelines in 23 European Countries.

    Kopsidas, Ioannis / Vergnano, Stefania / Spyridis, Nikos / Zaoutis, Theoklis / Patel, Sanjay

    The Pediatric infectious disease journal

    2020  Volume 39, Issue 11, Page(s) e359–e362

    Abstract: Background: Misuse, overuse of antimicrobials and increasing rates of antimicrobial resistance are well-recognized problems throughout Europe. The aim of this survey was to describe the current pediatric antibiotic stewardship (PAS) landscape across ... ...

    Abstract Background: Misuse, overuse of antimicrobials and increasing rates of antimicrobial resistance are well-recognized problems throughout Europe. The aim of this survey was to describe the current pediatric antibiotic stewardship (PAS) landscape across Europe and identify gaps, in terms of national programs, networks and guidelines.
    Methods: A survey of 17 questions was circulated in July 2019 among 24 European pediatric infectious disease researchers and clinicians, professors and heads of department on the existence of PAS programs, national networks and meetings, established competencies, metrics and guidelines.
    Results: We received responses from 23 countries. National guidelines on the management of children with common infections treated in hospital settings exist in 15 of 23 (70%); only 8 of 15 (53%) had been updated within the previous 4 years. Most provide guidance on antibiotic initiation and duration (14 of 15, 93%), but few on when to transition from intravenous to oral antibiotics (7 of 15, 47%). National PAS competencies have only been developed in 4 countries; only 1 addressed both community and hospital prescribing. Organized national PAS networks are only established in the United Kingdom and Germany; 21 of 23, 91% countries had no agreed metric for antibiotic prescribing in children; 2 of 23 were based on daily defined doses.
    Conclusions: Fragmented implementation of PAS programs, no agreed metrics, lack of established PAS competencies and national PAS networks along with inexistent funding is alarming in view of existing high rates of antimicrobial resistance in Europe.
    MeSH term(s) Anti-Bacterial Agents/therapeutic use ; Antimicrobial Stewardship/standards ; Child ; Drug Resistance, Bacterial ; Drug Utilization/standards ; Europe ; Humans ; Practice Guidelines as Topic ; Surveys and Questionnaires
    Chemical Substances Anti-Bacterial Agents
    Language English
    Publishing date 2020-08-06
    Publishing country United States
    Document type Journal Article ; Multicenter Study
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000002835
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Listeria infection in young infants: results from a national surveillance study in the UK and Ireland.

    Vergnano, Stefania / Godbole, Gauri / Simbo, Ameze / Smith-Palmer, Alison / Cormican, Martin / Anthony, Mark / Heath, Paul T

    Archives of disease in childhood

    2021  Volume 106, Issue 12, Page(s) 1207–1210

    Abstract: Objectives: To describe the epidemiology, age at infection, clinical characteristics and outcome of listeria infection in young infants to inform management and empiric antibiotic choice in young infants.: Design: Prospective 2-year surveillance of !# ...

    Abstract Objectives: To describe the epidemiology, age at infection, clinical characteristics and outcome of listeria infection in young infants to inform management and empiric antibiotic choice in young infants.
    Design: Prospective 2-year surveillance of
    Setting: National population study (England, Wales, Scotland and the Ireland) PATIENTS: All infants under 90 days with proven or probable invasive listeriosis MAIN OUTCOME MEASURES: Incidence, mortality, age of infection, clinical characteristics and outcome RESULTS: During a 2-year period (2017-2019), 27 cases of listeriosis in infants <90 days of age were reported. The incidence of listeriosis in this study was 1.8 per 100 000 live births with 7% mortality (2/27). Nearly all cases presented within the first 24 hours of life (26/27). The majority (20/27, 74%) were born preterm and 16/24 (67%) were born to women from ethnic minority backgrounds.
    Conclusions: Invasive listeriosis in young infants in the UK and Ireland is rare and presents early in the neonatal period. National guidelines that recommend the use of amoxicillin as part of empiric regimes for sepsis and meningitis in infants over 1 month of age should be modified.
    MeSH term(s) Female ; Humans ; Incidence ; Infant ; Infant, Newborn ; Ireland/epidemiology ; Leukocytosis/cerebrospinal fluid ; Listeria monocytogenes/genetics ; Listeria monocytogenes/isolation & purification ; Listeriosis/diagnosis ; Listeriosis/epidemiology ; Male ; Polymerase Chain Reaction ; Population Surveillance/methods ; Prospective Studies ; United Kingdom/epidemiology
    Language English
    Publishing date 2021-05-13
    Publishing country England
    Document type Journal Article
    ZDB-ID 524-1
    ISSN 1468-2044 ; 0003-9888 ; 1359-2998
    ISSN (online) 1468-2044
    ISSN 0003-9888 ; 1359-2998
    DOI 10.1136/archdischild-2021-321602
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article: Antimicrobial resistance in paediatric medicine

    Vergnano, Stefania / Sharland, Michael

    Journal of Pediatric Infectious Diseases

    2014  Volume 09, Issue 03, Page(s) 123–125

    Language English
    Publishing date 2014-09-01
    Publisher Georg Thieme Verlag KG
    Publishing place Stuttgart ; New York
    Document type Article
    ZDB-ID 2236947-8
    ISSN 1305-7693 ; 1305-7707 ; 1871-0336
    ISSN (online) 1305-7693
    ISSN 1305-7707 ; 1871-0336
    DOI 10.3233/JPI-140424
    Database Thieme publisher's database

    More links

    Kategorien

  7. Article ; Online: Serious bacterial infections in neonates: improving reporting and case definitions.

    Vergnano, Stefania / Seale, Anna C / Fitchett, Elizabeth J A / Sharland, Mike / Heath, Paul T

    International health

    2017  Volume 9, Issue 3, Page(s) 148–155

    Abstract: Neonatal infections affect about 7 million neonates causing over 600 000 deaths every year. Estimating the burden is challenging as there are multiple reporting criteria and definitions for serious bacterial infections in neonates. Essential criteria for ...

    Abstract Neonatal infections affect about 7 million neonates causing over 600 000 deaths every year. Estimating the burden is challenging as there are multiple reporting criteria and definitions for serious bacterial infections in neonates. Essential criteria for reporting serious neonatal bacterial infections have recently been published as the STROBE-NI checklist and, in the context of maternal vaccination, definitions have been published by the Brighton Collaboration Global Alignment of Immunization safety Assessment in pregnancy (GAIA) project. Standardisation of reporting criteria is essential to allow data comparability. This an important step in providing a clearer picture of the burden of serious bacterial infections in neonates and a welcome progress for guiding new investments in interventions.
    Language English
    Publishing date 2017-05-01
    Publishing country England
    Document type Journal Article
    ZDB-ID 2526175-7
    ISSN 1876-3405 ; 1876-3413
    ISSN (online) 1876-3405
    ISSN 1876-3413
    DOI 10.1093/inthealth/ihx011
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Severe refractory Kawasaki disease in seven infants in the COVID-19 era.

    Vergnano, Stefania / Alders, Nele / Armstrong, Catherine / Bamber, Andrew R / Bandi, Srini / Evans, Jennifer A / Hajiani, Nadia / Kenny, Julia / Kucera, Filip / Tometzki, Andrew / Uzun, Orhan / Wilkinson, Nick / Ramanan, Athimalaipet V

    The Lancet. Rheumatology

    2020  Volume 2, Issue 9, Page(s) e520

    Keywords covid19
    Language English
    Publishing date 2020-07-10
    Publishing country England
    Document type Journal Article
    ISSN 2665-9913
    ISSN (online) 2665-9913
    DOI 10.1016/S2665-9913(20)30231-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pediatric Antifungal Prescribing Patterns Identify Significant Opportunities to Rationalize Antifungal Use in Children.

    Ferreras-Antolín, Laura / Irwin, Adam / Atra, Ayad / Chapelle, Faye / Drysdale, Simon B / Emonts, Marieke / McMaster, Paddy / Paulus, Stephane / Patel, Sanjay / Rompola, Menie / Vergnano, Stefania / Whittaker, Elizabeth / Warris, Adilia

    The Pediatric infectious disease journal

    2021  Volume 41, Issue 3, Page(s) e69–e74

    Abstract: Objective: The need for pediatric antifungal stewardship programs has been driven by an increasing consumption of antifungals for prophylactic and empirical use. Drivers and rational of antifungal prescribing need to be identified to optimize ... ...

    Abstract Objective: The need for pediatric antifungal stewardship programs has been driven by an increasing consumption of antifungals for prophylactic and empirical use. Drivers and rational of antifungal prescribing need to be identified to optimize prescription behaviors.
    Methods: A prospective modified weekly Point Prevalence Survey capturing antifungal prescriptions for children (> 90 days to < 18 years of age) in 12 centers in England during 26 consecutive weeks was performed. Demographic, diagnostic and treatment information was collected for each patient. Data were entered into an online REDCap database.
    Results: One thousand two hundred fifty-eight prescriptions were included for 656 pediatric patients, 44.9% were girls, with a median age of 6.4 years (interquartile range, 2.5-11.3). Most common underlying condition was malignancy (55.5%). Four hundred nineteen (63.9%) received antifungals for prophylaxis, and 237 (36.1%) for treatment. Among patients receiving antifungal prophylaxis, 40.2% did not belong to a high-risk group. In those receiving antifungal treatment, 45.9%, 29.4%, 5.1% and 19.6% had a diagnosis of suspected, possible, probable of proven invasive fungal disease (IFD), respectively. Proven IFD was diagnosed in 78 patients, 84.6% (n = 66) suffered from invasive candidiasis and 15.4% (n = 12) from an invasive mold infection. Liposomal amphotericin B was the most commonly prescribed antifungal for both prophylaxis (36.6%) and empiric and preemptive treatment (47.9%). Throughout the duration of the study, 72 (11.0%) patients received combination antifungal therapy.
    Conclusions: Antifungal use in pediatric patients is dominated by liposomal amphotericin B and often without evidence for the presence of IFD. A significant proportion of prophylactic and empiric antifungal use was seen in pediatric patients not at high-risk for IFD.
    MeSH term(s) Adolescent ; Amphotericin B ; Antifungal Agents/therapeutic use ; Antimicrobial Stewardship/methods ; Antiprotozoal Agents/therapeutic use ; Azoles/therapeutic use ; Candidiasis/drug therapy ; Candidiasis, Invasive/drug therapy ; Child ; Child, Preschool ; England ; Female ; Humans ; Invasive Fungal Infections/drug therapy ; Liposomes/therapeutic use ; Male ; Prescriptions ; Prospective Studies
    Chemical Substances Antifungal Agents ; Antiprotozoal Agents ; Azoles ; Liposomes ; liposomal amphotericin B ; Amphotericin B (7XU7A7DROE)
    Language English
    Publishing date 2021-11-16
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 392481-6
    ISSN 1532-0987 ; 0891-3668
    ISSN (online) 1532-0987
    ISSN 0891-3668
    DOI 10.1097/INF.0000000000003402
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: The current and future roles of neonatal infection surveillance programmes in combating antimicrobial resistance.

    Cailes, Benjamin / Vergnano, Stefania / Kortsalioudaki, Christina / Heath, Paul / Sharland, Mike

    Early human development

    2015  Volume 91, Issue 11, Page(s) 613–618

    Abstract: Neonatal sepsis is an important cause of morbidity and mortality, particularly in premature or low birth weight babies. Hospital-acquired blood stream infections represent a significant and largely preventable cause of disease in this population. ... ...

    Abstract Neonatal sepsis is an important cause of morbidity and mortality, particularly in premature or low birth weight babies. Hospital-acquired blood stream infections represent a significant and largely preventable cause of disease in this population. Neonatal units have been identified as a common site for the development and transmission of antimicrobial-resistant pathogens, a significant issue in modern medicine. Neonatal surveillance programmes collect prospective data on infection rates and may be used to optimise therapy, benchmark practice and develop quality improvement programmes. Despite this, the number of networks is relatively few and these are largely concentrated in resource-rich nations. Furthermore, surveillance definitions may vary between programmes impairing our ability to draw comparisons between them. Better harmonisation is required between networks to ensure that they achieve their potential as a valuable tool for benchmarking of hospital-acquired infection rates between units.
    MeSH term(s) Anti-Infective Agents/therapeutic use ; Cross Infection/congenital ; Cross Infection/epidemiology ; Cross Infection/prevention & control ; Drug Resistance, Microbial ; Humans ; Infant, Newborn ; Infant, Newborn, Diseases/epidemiology ; Infant, Newborn, Diseases/prevention & control ; Infection/congenital ; Infection/epidemiology ; Infection Control/methods ; Infection Control/trends ; Intensive Care Units, Neonatal ; Population Surveillance/methods ; Sepsis/congenital ; Sepsis/epidemiology ; Sepsis/prevention & control
    Chemical Substances Anti-Infective Agents
    Language English
    Publishing date 2015-11
    Publishing country Ireland
    Document type Journal Article ; Review
    ZDB-ID 752532-1
    ISSN 1872-6232 ; 0378-3782
    ISSN (online) 1872-6232
    ISSN 0378-3782
    DOI 10.1016/j.earlhumdev.2015.08.012
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top